Theriva Biologics
TOVX
TOVX
32 hedge funds and large institutions have $5.8M invested in Theriva Biologics in 2021 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 10 increasing their positions, 1 reducing their positions, and 3 closing their positions.
Holders
32
Holders Change
+11
Holders Change %
+52.38%
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
10
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
BlackRock
New York
|
$1.6M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$1.37M |
3 |
MP
3
MSD Partners
New York
|
$655K |
4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$586K |
5 |
5
UBS Group
Zurich,
Switzerland
|
$393K |